| Dr Rakesh Arora, MD | |
|
14300 Gallant Fox Ln, Suite 222, Bowie, MD 20715-4003 | |
| (301) 262-7800 | |
| (301) 805-0782 |
| Full Name | Dr Rakesh Arora |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 54 Years |
| Location | 14300 Gallant Fox Ln, Bowie, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013085505 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | D20108 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Care Center Llc | 3274801139 | 192 |
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
A new multi-center study has reaffirmed the difference between the sexes – at least when it comes to colorectal cancer detection and prevention.
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.
A study published today in the prestigious New England Journal of Medicine offers the most in-depth assessment yet of the safety and effectiveness of a high-tech alternative to brain surgery to treat the uncontrollable shaking caused by the most common movement disorder.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
› Verified 5 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
A new multi-center study has reaffirmed the difference between the sexes – at least when it comes to colorectal cancer detection and prevention.
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.
A study published today in the prestigious New England Journal of Medicine offers the most in-depth assessment yet of the safety and effectiveness of a high-tech alternative to brain surgery to treat the uncontrollable shaking caused by the most common movement disorder.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
› Verified 5 days ago
| Entity Name | Privia Care Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164874426 PECOS PAC ID: 3274801139 Enrollment ID: O20170616001775 |
News Archive
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
A new multi-center study has reaffirmed the difference between the sexes – at least when it comes to colorectal cancer detection and prevention.
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.
A study published today in the prestigious New England Journal of Medicine offers the most in-depth assessment yet of the safety and effectiveness of a high-tech alternative to brain surgery to treat the uncontrollable shaking caused by the most common movement disorder.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rakesh Arora, MD 14300 Gallant Fox Ln, Suite 222, Bowie, MD 20715-4003 Ph: (301) 262-7800 | Dr Rakesh Arora, MD 14300 Gallant Fox Ln, Suite 222, Bowie, MD 20715-4003 Ph: (301) 262-7800 |
News Archive
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
A new multi-center study has reaffirmed the difference between the sexes – at least when it comes to colorectal cancer detection and prevention.
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.
A study published today in the prestigious New England Journal of Medicine offers the most in-depth assessment yet of the safety and effectiveness of a high-tech alternative to brain surgery to treat the uncontrollable shaking caused by the most common movement disorder.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
› Verified 5 days ago
Emma Rebecca Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17001 Science Dr, Suite 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Paul David Giles, DO, MS Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17001 Science Dr Ste 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Tahani Laila Williams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13108 Hunters Ridge Ln, Bowie, MD 20721 Phone: 301-332-9986 | |
Dr. Sonia Marie Rhoden-salmon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15459 Annapolis Rd, Bowie, MD 20715 Phone: 240-544-0676 | |
Mariama Jeloh Bah-sow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 17001 Science Dr Ste 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Konni Elaine Bringman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4201 Mitchellville Rd, Suite 102, Bowie, MD 20716 Phone: 301-262-5900 Fax: 410-741-0865 |